Cargando…
Bone Morphogenic Protein Is a Viable Adjunct for Fusion in Minimally Invasive Transforaminal Lumbar Interbody Fusion
STUDY DESIGN: Comparison of prospectively collected data of patients undergoing minimally invasive surgery transforaminal lumbar interbody fusion (MIS-TLIF) with and without recombinant human bone morphogenic protein 2 (BMP). PURPOSE: To compare the clinical, radiological outcome and complications o...
Autores principales: | Siddiqui, M Mashfiqul Arafin, Sta.Ana, Ana Rosario P., Yeo, William, Yue, Wai-Mun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Spine Surgery
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5165000/ https://www.ncbi.nlm.nih.gov/pubmed/27994786 http://dx.doi.org/10.4184/asj.2016.10.6.1091 |
Ejemplares similares
-
Minimal invasive transforaminal lumbar interbody fusion versus open transforaminal lumbar interbody fusion
por: Kulkarni, Arvind G, et al.
Publicado: (2016) -
Comparison between Minimally Invasive Transforaminal Lumbar Interbody Fusion and Conventional Open Transforaminal Lumbar Interbody Fusion: An Updated Meta-analysis
por: Xie, Lei, et al.
Publicado: (2016) -
Endoscopic Lumbar Interbody Fusion, Minimally Invasive Transforaminal Lumbar Interbody Fusion, and Open Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Diseases: A Systematic Review and Network Meta-Analysis
por: Hu, Xijian, et al.
Publicado: (2023) -
Percutaneous Endoscopic Transforaminal Lumbar Interbody Fusion: Technique Note and Comparison of Early Outcomes with Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar Spondylolisthesis
por: Zhang, Hao, et al.
Publicado: (2021) -
Comparison of hidden blood loss and clinical efficacy of percutaneous endoscopic transforaminal lumbar interbody fusion and minimally invasive transforaminal lumbar interbody fusion
por: Ge, Meng, et al.
Publicado: (2022)